Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitos Technologies is a specialist in the design and manufacture of single-use fluid handling systems and components for the biopharmaceutical industry. The company provides a range of products including high-purity tubing, connectors, and manifolds designed to streamline the production of biologics, vaccines, and other pharmaceutical products. Mitos is recognized for its expertise in single-use technology (SUT), which helps manufacturers reduce cross-contamination risks and decrease cleaning validation requirements. In 2008, the company was acquired by Parker Hannifin to bolster its life sciences and bioprocessing portfolio. Its technologies are now integrated into Parker's Bioscience and Filtration divisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitos Technologies.